Literature DB >> 23570431

Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review.

Kiraat D Munshi1, Ya-Chen T Shih, Lawrence M Brown, Samuel Dagogo-Jack, Jim Y Wan, Junling Wang.   

Abstract

The emphasis on eliminating racial and ethnic disparities in healthcare has received national attention, with various policy initiatives addressing this problem and proposing solutions. However, in the current economic era requiring tight monetary constraints, emphasis is increasingly being placed on economic efficiency, which often conflicts with the equality doctrine upon which many policies have been framed. The authors' review aims to highlight the disparity implications of one such policy provision - the predominantly utilization-based eligibility criteria for medication therapy management services under Medicare Part D - by identifying studies that have documented racial and ethnic disparities in health status and the use of and spending on prescription medications. Future design and evaluation of various regulations and legislations employing utilization-based eligibility criteria must use caution in order to strike an equity-efficiency balance.

Entities:  

Mesh:

Year:  2013        PMID: 23570431      PMCID: PMC3623017          DOI: 10.1586/erp.13.6

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  64 in total

1.  Racial and ethnic differences in access to and use of health care services, 1977 to 1996.

Authors:  R M Weinick; S H Zuvekas; J W Cohen
Journal:  Med Care Res Rev       Date:  2000       Impact factor: 3.929

2.  Levels of racism: a theoretic framework and a gardener's tale.

Authors:  C P Jones
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

3.  Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.

Authors:  Julie Magno Zito; Daniel J Safer; Ilene H Zuckerman; James F Gardner; Karen Soeken
Journal:  Psychiatr Serv       Date:  2005-02       Impact factor: 3.084

4.  Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.

Authors:  Junling Wang; Jason M Noel; Ilene H Zuckerman; Nancy A Miller; Fadia T Shaya; C Daniel Mullins
Journal:  Med Care Res Rev       Date:  2006-12       Impact factor: 3.929

5.  The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

6.  Prescriptions for cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory agents in a medicaid managed care population: African Americans versus Caucasians.

Authors:  Fadia T Shaya; Steven Blume
Journal:  Pain Med       Date:  2005 Jan-Feb       Impact factor: 3.750

7.  Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

Authors:  Kelly A Gebo; John A Fleishman; Richard Conviser; Erin D Reilly; P Todd Korthuis; Richard D Moore; James Hellinger; Philip Keiser; Haya R Rubin; Lawrence Crane; Fred J Hellinger; W Christopher Mathews
Journal:  J Acquir Immune Defic Syndr       Date:  2005-01-01       Impact factor: 3.731

8.  Race, stability of health insurance coverage, and prescription medication use.

Authors:  Karen P Winters; Sharon B Wyatt; Todd G Nick; Peggy O Hewlett; John C Hyde; Audwin B Fletcher
Journal:  ABNF J       Date:  2010

9.  Influence of age, sex, and race on prescription drug use among Georgia Medicaid recipients.

Authors:  L Kotzan; N V Carroll; J A Kotzan
Journal:  Am J Hosp Pharm       Date:  1989-02

10.  Racial disparities in prescription drug use among dually eligible beneficiaries.

Authors:  Jennifer Schore; Randall Brown; Bridget Lavin
Journal:  Health Care Financ Rev       Date:  2003
View more
  4 in total

1.  Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.

Authors:  Junling Wang; Yanru Qiao; Christina A Spivey; Christine Li; Caroline Clark; Yuewen Deng; Flora Liu; Jeffrey Tillman; Marie Chisholm-Burns
Journal:  J Pharm Health Serv Res       Date:  2016-05-26

2.  Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.

Authors:  Xiaobei Dong; Chi Chun Steve Tsang; Shirong Zhao; Jim Y Wan; Ya-Chen Tina Shih; Marie A Chisholm-Burns; Samuel Dagogo-Jack; William C Cushman; Lisa E Hines; Junling Wang
Journal:  Am Health Drug Benefits       Date:  2021-09

3.  Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.

Authors:  Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie A Chisholm-Burns
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

4.  Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.

Authors:  Xiaobei Dong; Chi Chun Steve Tsang; Jim Y Wan; Yachen Tina Shih; Marie A Chisholm-Burns; Samuel Dagogo-Jack; William C Cushman; Lisa E Hines; Junling Wang
Journal:  Explor Res Clin Soc Pharm       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.